MAURI MARIO
Ruolo:
Tecnico - amministrativo
E-mail:
Pubblicazioni
- Pelucchi, S., Ravasi, G., Arosio, C., Mauri, M., Piazza, R., Mariani, R., et al. (2021). Hif1a: A putative modifier of hemochromatosis. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 22(3), 1-15. Dettaglio
- Karantzoulis, A., Conti, E., Slongo, M., Rodriguez-Menendez, V., Mauri, M., Da Re, F., et al. (2020). CLEARANCE OF BETA-AMYLOID OLIGOMERS BY PERIPHERAL MONOCYTES: FURTHER OBSERVATIONS REGARDING THE MODULATORY ROLE OF DONEPEZIL. Intervento presentato a: 51st Annual Conference of the Italian Society of Neurology, Virtual edition [10.1007/s10072-020-04753-3]. Dettaglio
- Magistroni, V., Mauri, M., D'Aliberti, D., Mezzatesta, C., Crespiatico, I., Nava, M., et al. (2019). De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways. HAEMATOLOGICA, 104(9), 1789-1797 [10.3324/haematol.2017.179937]. Dettaglio
- Fontana, D., Mauri, M., Niro, A., Massimino, L., Bertagna, M., Zambrotta, G., et al. (2018). ETNK1 MUTATIONS INCREASE MITOCHONDRIAL ACTIVITY AND PROMOTE DNA DAMAGE THROUGH ROS PRODUCTION. Intervento presentato a: XV Congress of the Italian Society of Experimental Hematology, Rimini, Italy. Dettaglio
- Fontana, D., Mauri, M., Niro, A., Massimino, L., Bertagna, M., Zambrotta, G., et al. (2018). ETNK1 mutations promote ROS production and DNA damage through increased mitochondrial activity. In Proceedings: AACR Annual Meeting 2018. Dettaglio